Hypocretin (orexin) receptor subtypes differentially enhance acetylcholine release and activate G protein subtypes in rat pontine reticular formation

Journal of Pharmacology and Experimental Therapeutics

Volumn 317, Issue 1, 2006, Pages 163-171

  Bernard, René ^a   Lydic, Ralph ^a   Baghdoyan, Helen A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE DERIVATIVE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); N PARA SULFOPHENYLADENOSINE; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; PERTUSSIS TOXIN; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RETICULAR FORMATION;

ACETYLCHOLINE; ANIMALS; BRAIN STEM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; GTP-BINDING PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICRODIALYSIS; NEUROPEPTIDES; PERTUSSIS TOXIN; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE;

EID: 33645116975     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.097071     Document Type: Article

References (43)

1. Bernard R, Lydic R, and Baghdoyan HA (2003) Hypocretin-1 causes G protein activation and increases ACh release in rat pons. Eur J Neurosci 18:1775-1785.
2. 35S]GTPγS autoradiography, in The Orexin/Hypocretin System: Physiology and Pathophysiology (Nishino S and Sakurai T eds) pp 83-96, Humana Press Inc., Totowa, NJ.
3. Birnbaumer L, Abramowitz J, and Brown AM (1990) Receptor-effector coupling by G proteins. Biochim Biophys Acta 1031:163-224.
4. Carty D (1994) Pertussis toxin-catalyzed ADP-ribosylation of G proteins. Methods Enzymol 237:63-70.
5. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, et al. (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98:437-451.
6. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS 2nd, et al. (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95:322-327.
7. Devi LA (2001) Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. Trends Pharm Sci 22:532-537.
8. Greco MA and Shiromani PJ (2001) Hypocretin receptor protein and mRNA expression in the dorsolateral pons of rats. Brain Res Mol Brain Res 88:176-182.
9. Gronier B and Rasmussen K (1999) Pertussis toxin treatment differentially affects cholinergic and dopaminergic receptor stimulation of midbrain dopaminergic neurons. Neuropharmacology 38:1903-1912.
10. 35S]GTPγS binding assay: approaches and applications in pharmacology. Life Sci 74:489-508.
11. Ho MK and Wong YK (2001) G(z) signaling: emerging divergence from G(i) signaling. Oncogene 20:1615-1625.
12. Hoang QV, Bajic D, Yanagisawa M, Nakajima S, and Nakajima Y (2003) Effects of orexin (hypocretin) on GIRK channels. J Neurophysiol 90:693-702.
13. Holmqvist T, Johansson L, Ostman M, Ammoun S, Akerman KEO, and Kukkonen JP (2005) OX1 orexin receptors couple to adenylyl cyclase regulation via multiple mechanisms. J Biol Chem 280:6570-6579.
14. Karteris E and Randeva HS (2003) Orexin receptors and G-protein coupling: evidence for another "promiscuous" seven transmembrane domain receptor. J Pharmacol Sci 93:126-128.
15. Kilduff TS and Peyron C (2000) The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci 23:359-365.
16. B receptor binding in rat brain. Neuroscience 52:73-81.
17. Kukkonen JP, Holmqvist T, Ammoun S, and Åkerman KE (2002) Functions of the orexinergic/hypocretinergic system. Am J Physiol Cell Physiol 283:C1567-C1591.
18. 35S]GTPγS autoradiography: a powerful functional approach with expanding potential for neuropharmacological studies on receptors coupled to Gi family of G proteins. Curr Neuropharmacol 2:191-206.
19. Lee MG, Hassani OK, and Jones BE (2005) Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci 25:6716-6720.
20. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, and Mignot E (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98:365-376.
21. Lydic R and Baghdoyan HA (2005) Sleep, anesthesiology and the neurobiology of arousal state control. Anesthesiology 103:1268-1295.
22. Mileykovskiy BY, Kiyashchenko LI, and Siegel JM (2005) Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 46:787-798.
23. Nishino S, Ripley B, Overeem S, Lammers GJ, and Mignot E (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355:39-40.
24. Paxinos G and Watson C (1998) The Rat Brain in Stereotaxic Coordinates, 4th ed, Academic Press, New York.
25. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, and Kilduff TS (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18:9996-10015.
26. Ribeiro JA, Sebastiao AM, and de Mendonca A (2003) Adenosine receptors in the nervous system: pathophysiological implications. Prog Neurobiol 68:377-392.
27. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-585.
28. 35S]GTPγS binding in hcrtr 2-transfected cell lines and in brain homogenate. Biochem Biophys Res Commun 294:615-620.
29. Smart D and Jerman JC (2002) The physiology and pharmacology of the orexins. Pharmacol Ther 94:51-61.
30. Smart D, Jerman JC, Brough SJ, Rushton SL, Murdock PR, Jewitt F, Elshourbagy NA, Ellis CE, Middlemiss DN, and Brown F (1999) Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR. Br J Pharmacol 128:1-3.
31. Smart D, Sabido-David C, Brough SJ, Jewitt F, Johns A, Porter RA, and Jerman JC (2001) SB-334867-A: the first selective orexin-1 receptor antagonist. Br J Pharmacol 132:1179-1182.
32. Soto-Calderon H, Lydic R, and Baghdoyan HA (2005) GABA levels are increased in the pontine reticular nucleus, oral part (PnO) of anesthetized rat by dialysis administration of hypocretin-1 (orexin A). Sleep 28 (Abstr Suppl):0036.
33. 35S] GTPγS autoradiography. Brain Res Rev 38:148-164.
34. Tanase D, Baghdoyan HA, and Lydic R (2003) Dialysis delivery of an adenosine A1 receptor agonist to the pontine reticular formation decreases acetylcholine release and increases anesthesia recovery time. Anesthesiology 98:912-920.
35. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Comford M, and Siegel JM (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469-474.
36. Tzavara ET, Wade M, and Nomikos GG (2003) Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: site and mechanism of action. J Neurosci 23:9374-9384.
37. van den Pol AN, Gao XB, Obrietan K, Kilduff TS, and Belousov AB (1998) Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci 18:7962-7971.
38. van den Top M, Nolan MF, Lee K, Richardson PJ, Buijs RM, Davies CH, and Spanswick D (2003) Orexins induce increased excitability and synchronisation of rat sympathetic preganglionic neurones. J Physiol 549.3:809-821.
39. van der Ploeg I, Cintra A, Altiok N, Askeloef P, Fuxe K, and Fredholm BB (1991) Limited distribution of pertussis toxin in rat brain after injection into the lateral cerebral ventricles. Neuroscience 44:205-214.
40. Vazquez-Prado J, Casas-Gonzalez P, and Garcia-Sainz JA (2003) G protein-coupled receptor cross talk: pivotal roles of protein phosphorylation and protein-protein interaction. Cell Signal 15:549-557.
41. Xi M-C, Fung SJ, Yamuy J, Morales FR, and Chase MH (2002) Induction of active (REM) sleep by microinjection of hypocretin into the nucleus pontis oralis of the cat. J Neurophysiol 87:2880-2888.
42. Xi M-C, Morales FR, and Chase MH (2004) Interactions between GABAergic and cholinergic processes in the nucleus pontis oralis: neuronal mechanisms controlling active (rapid eye movement) sleep and wakefulness. J Neurosci 24:10670-10678.
43. Zhu Y, Miwa Y, Yamanaka A, Yada T, Shibahara M, Abe Y, Sakurai T, and Goto K (2003) Orexin receptor type-1 couples exclusively to pertussis toxin-insensitive G-proteins, while orexin receptor type-2 couples to both pertussis toxin-sensitive and -insensitive G-proteins. J Pharmacol Sci 92:259-266.